Publicaciones en colaboración con investigadores/as de Universidad de Castilla-La Mancha (7)

2023

  1. Guanylation Reactions for the Rational Design of Cancer Therapeutic Agents

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2022

  1. Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

  2. Clinical considerations for the design of PROTACs in cancer

    Molecular Cancer, Vol. 21, Núm. 1

2021

  1. MZ1 co-operates with trastuzumab in HER2 positive breast cancer

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

2019

  1. Poly(Cyclohexene phthalate) nanoparticles for controlled dasatinib delivery in breast cancer therapy

    Nanomaterials, Vol. 9, Núm. 9

  2. Screening and preliminary biochemical and biological studies of [RuCl(p-cymene)(N, N-bis(diphenylphosphino)-isopropylamine)][BF4] in Breast Cancer Models

    ACS Omega, Vol. 4, Núm. 8, pp. 13005-13014

  3. Trastuzumab-targeted biodegradable nanoparticles for enhanced delivery of dasatinib in HER2+ metastasic breast cancer

    Nanomaterials, Vol. 9, Núm. 12